Federal Judge Keeps Luigi Mangione Assassination Trial on Fall Schedule Despite Defense Delay Bid
A federal judge in New York rejected a request by accused assassin Luigi Mangione’s defense team to delay his federal trial in the killing of UnitedHealthcare CEO Brian Thompson, keeping the case on track for jury selection in the fall and possible opening statements on Oct. 26 or Nov. 2. Judge Margaret Garnett said she would not let her courtroom be “held hostage” by the timetable of a separate New York state murder trial, which is scheduled to start June 8, and stressed that her focus is on ensuring a fair federal trial regardless of what happens in state court. Defense attorney Karen Friedman Agnifilo argued for several additional months to prepare after the state proceeding, while Assistant U.S. Attorney Dominic Gentile countered that both prosecutions rely on the same core facts and witnesses and that logistical issues could be handled by adjusting jury questionnaires originally drafted for a capital case, since the death penalty is no longer on the table. Garnett indicated she does not view the federal case as especially complex, but acknowledged concern that a highly publicized state trial could complicate federal jury selection. Mangione faces multiple state and federal charges over the December 2024 shooting of Thompson outside a Midtown Manhattan hotel, an attack prosecutors describe as a politically motivated assassination that has drawn intense media and public attention.
📌 Key Facts
- Judge Margaret Garnett declined to delay Luigi Mangione’s federal trial, aiming for jury selection in the fall and openings on Oct. 26 or Nov. 2.
- Mangione’s state murder trial in New York Supreme Court is scheduled to begin June 8 and is expected to attract massive media attention.
- Prosecutors told the court the federal and state cases are based on the same facts and witnesses, and noted that the federal case is no longer capital after the death penalty was removed.
📊 Relevant Data
The dual sovereignty doctrine permits federal and state governments to prosecute an individual for the same conduct without violating the Double Jeopardy Clause, as they are considered separate sovereigns with distinct laws.
Amdt5.3.3 Dual Sovereignty Doctrine — Constitution Annotated
In a 2023 study of preventive care claims, non-Hispanic White patients had a denial rate of 1.13%, compared to 2.72% for Asian patients, 2.18% for Black patients, and 1.68% for Hispanic patients, with population percentages in the U.S. being approximately 59% White, 19% Hispanic, 13% Black, and 6% Asian.
Social Determinants of Health and Insurance Claim Denials for Preventive Care — JAMA Network Open
As of 2023, uninsured rates among adults under 65 were 6.5% for White individuals, 5.8% for Asian individuals, 9.7% for Black individuals, and 17.9% for Hispanic individuals, with Hispanic people comprising about 19% of the U.S. population, Black 13%, White 59%, and Asian 6%.
📰 Source Timeline (1)
Follow how coverage of this story developed over time